Background & Aims: Patients with liver disease often show substantial changes in their hemostatic system, which may aggravate further during liver transplantation. Recently, thrombin generation in patients with stable disease was shown to be indistinguishable from controls provided thrombomodulin, the natural activator of the anticoagulant protein C system, was added to the plasma. These results indicated that the hemostatic balance is preserved in patients with liver disease, despite conventional coagulation tests suggest otherwise. Methods: Here we examined thrombin generation profiles in serial plasma samples taken from ten consecutive patients undergoing liver transplantation. Results: At all time points, the endogenous thrombin potenti...
Impaired coagulation factor synthesis in cirrhosis causes a reduction of most pro-and anticoagulant ...
BACKGROUND & AIMS: Patients undergoing liver transplantation have complex changes in their hemostati...
The role played by coagulation defects in the occurrence of bleeding in cirrhosis is still unclear. ...
BACKGROUND & AIMS: Patients with liver disease often show substantial changes in their hemostatic sy...
BACKGROUND: Plasma transfusion remains the mainstay hemostatic therapy during liver transplantation ...
BACKGROUND: Recombinant soluble human thrombomodulin (ART-123) is an anticoagulant and anti-inflamma...
Background: The long-term risk of thrombotic and vascular complications is elevated in liver transpl...
BackgroundConventional coagulation tests are frequently prolonged after liver surgery, suggesting a ...
Purpose of review Hemostatic alterations in cirrhosis involve molecular pathways that both promote a...
. Background: It has been well established that hemostatic potential in patients with chronic liver ...
Introduction. Recent studies have indicated an increased incidence of thrombotic vascular complicati...
Traditionally, perioperative bleeding complications were a major concern during orthotopic liver tra...
Item does not contain fulltextBACKGROUND: The platelet count varies considerably between individuals...
Background/aims: Thrombocytopenia in patients with advanced liver disease may stem from a deficient ...
Cirrhosis is characterized by a complex coagulation defect leading to the prolongation of the prothr...
Impaired coagulation factor synthesis in cirrhosis causes a reduction of most pro-and anticoagulant ...
BACKGROUND & AIMS: Patients undergoing liver transplantation have complex changes in their hemostati...
The role played by coagulation defects in the occurrence of bleeding in cirrhosis is still unclear. ...
BACKGROUND & AIMS: Patients with liver disease often show substantial changes in their hemostatic sy...
BACKGROUND: Plasma transfusion remains the mainstay hemostatic therapy during liver transplantation ...
BACKGROUND: Recombinant soluble human thrombomodulin (ART-123) is an anticoagulant and anti-inflamma...
Background: The long-term risk of thrombotic and vascular complications is elevated in liver transpl...
BackgroundConventional coagulation tests are frequently prolonged after liver surgery, suggesting a ...
Purpose of review Hemostatic alterations in cirrhosis involve molecular pathways that both promote a...
. Background: It has been well established that hemostatic potential in patients with chronic liver ...
Introduction. Recent studies have indicated an increased incidence of thrombotic vascular complicati...
Traditionally, perioperative bleeding complications were a major concern during orthotopic liver tra...
Item does not contain fulltextBACKGROUND: The platelet count varies considerably between individuals...
Background/aims: Thrombocytopenia in patients with advanced liver disease may stem from a deficient ...
Cirrhosis is characterized by a complex coagulation defect leading to the prolongation of the prothr...
Impaired coagulation factor synthesis in cirrhosis causes a reduction of most pro-and anticoagulant ...
BACKGROUND & AIMS: Patients undergoing liver transplantation have complex changes in their hemostati...
The role played by coagulation defects in the occurrence of bleeding in cirrhosis is still unclear. ...